SMS Pharmaceuticals Ltd share price declined 5.65% to Rs 373.75 after the company's net profit slipped by 3.63% to Rs 20.2 crore, while revenue from operations reduced 13.02% to Rs 206.96 crore in Q2FY26 over Q1FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 23.86 lakh crore, rising 6%. It has improved by 2.79% over last one week and rallied by 15.59% in last one month while the market capitalization of SMS Pharmaceuticals Ltd has eased by 1.73% and 7.50% in the same period respectively. Profit before tax (PBT) of SMS Pharmaceuticals Ltd stood at Rs 27.21 crore in Q2 FY26, rising by 11.65% year-on-year, and gaining 0.52% quarter-on-quarter. EBITDA came in at Rs 39 crore, easing 1.11% YoY and gaining 5.04% sequentially. Total expenses reduced by 15.46% to Rs 176.0 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 136.65 crore, posting a minor increase of 6.38% YoY, while employee benefits expense was at Rs 23.54 crore, tumbling by 20.12% YoY. For the TTM ended FY26, revenue from operations rose 10.36% to Rs 782.75 crore, while net profit jumped 36.99% to Rs 67.4 crore, compared to previous TTM. EBITDA surged by 11398% to Rs 132.77 crore, and PBT witnessed a strong rise of 39.68% to Rs 92.34 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 81.71 crore in FY26, as against Rs 50.12 crore in FY25. SMS Pharmaceuticals Ltd rallied 57.57% in last one year, significantly outperforming the benchmark BSE Sensex which has eased by 4.36% during the same period.
